Navigation Links
Global Sales Veteran Jack McGovern Joins MediKeeper
Date:1/24/2008

SAN DIEGO, Jan. 24 /PRNewswire/ -- MediKeeper (http://www.medikeeper.com), a leading provider of technology solutions for the health and wellness industry, today announced its appointment of global sales veteran Jack McGovern as Senior VP/Sales to lead expansion of strategic sales initiatives.

MediKeeper's comprehensive suite of customizable, patient-centered tools and content empowers individuals to control their own health and wellness. Its Personal Health Record (PHR) helps improve the quality of health care while reducing costs for the individual and payer. MediKeeper was recently rated one of the top two privately owned PHR companies in the United States.

McGovern's move caps 15 years of increasingly successful sales efforts spanning multiple industries. His most recent success was founding, achieving exponential sales growth, and selling an online financial products and services company.

Before that endeavor he achieved record sales growth while reducing operating expenses at Realtor.com. Beyond his tremendous sales performance, he designed and implemented the sales coaching standards still used in the company today. Mr. McGovern's contributions helped advance Realtor.com to the position as the largest online real estate sales and marketing destination.

McGovern held several key sales and senior-level positions with both new and established companies, and has a consistent record of enhancing strategic planning, streamlining processes, and exceeding sales targets.

"MediKeeper's entering an exciting expansion phase. Jack's record of driving sustained growth across global markets makes him the ideal choice to lead our sales efforts," says MediKeeper CEO Dr. Bruce Tarzy. "His appointment reflects MediKeeper's ambition to remain a market leader in providing innovative health and wellness technology solutions."

"Employers, health care providers, employee benefit/we
'/>"/>

SOURCE MediKeeper
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Fleishman-Hillard Names FFI Global Cause for 2008
2. Lighting up the powerful global smoking lobby
3. Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
4. Global Environment partners provide additional $20 million to protect endangered habitats
5. Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine
6. NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired
7. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
10. Flagship Global Health Chairman Resigns
11. CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...fe remains unclear, researchers say , , ... suggests that enzyme replacement therapy can make...bry disease, a rare illness that affects the kidne..., linked to the lack of an enzyme that helps metab...ecause it boosts the risk for a stroke, heart atta...
(Date:12/2/2009)...Y., Dec. 2 Researchers ...in blood cancer research at the annual American So...s December 4-8, 2009. ,, Throughout the ASH co...) experts, including Chief Medical Officer Barton ...nt Services Hildy Dillon, and Vice President, Rese...
(Date:12/2/2009)...y federal government ends nine months of obstructi...RNewswire-USNewswire/ -- More than 2,300 healthcar...ilities across Southern California will soon vote ...Healthcare Workers (NUHW). ,, A majority of the... but SEIU delayed the election by filing frivolous...
(Date:12/2/2009)...al congress of the European Association of Echocar...an Society of Cardiology, where techniques of non-... New case reports will be presented at this year,...the role of this new technology. , Now, with su...likely that non-invasive imaging will gain more im...
(Date:12/2/2009)...ional Race Series to increase awareness of prostat... importance of early detection , ..., women, families, friends and neighbors – a...ipate in the Rudolph Ramble 5K. The Rudolph Rambl... which was launched by the Prostate Conditions Ed...
Breaking Medicine News(10 mins):Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:Media alert: EUROECHO 2009 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4
... announced today that it has submitted a supplemen...and Drug Administration (FDA) for VYVANSE(TM) (lis...ention Deficit Hyperactivity Disorder (ADHD) in ad... Matthew Emmens, Shire Chief Executive Officer. "W...
...he abattoir, especially because it is afflicted wi... the mad cow disease that took a heavy toll of th...year-old Freisian bull to the slaughterhouse is bu... the Wales health authorities. The bull is sacred...
...an alert following a malaria epidemic that has cla...people. "Doctors and paramedics have been ...uding mobile units, fanning out to vulnerable area...the mosquito-borne disease. "Between Janua...
...the war veterans who have come back after combat i...to the exposure to chemicals and other harmful sub...regions that are closely linked to learning and me...an Academy of Neurology's 59th Annual Meeting in B...
...evere chest pain today are much less likely to die...r counterparts even a few years ago, according to... time that a study has shown a significant drop in...t hospitals increased their use of certain drugs, ...
...iled to improve symptoms of moderate to severe chr... large, multi-center trial. The results o... trial of infliximab were published in the first i...ial commenting on the research, the failure of the...
Other Medicine News:Health News:VYVANSE(TM) Drug for the Treatment of ADHD in Adults 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2Health News:Malaria Claims 25 Lives in Assam 2Health News:Gulf War Veterans Exhibit Memory Impairment 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 3Health News:Good News for Sufferers of Heart Attack, Chest Pain 4Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2
(Date:12/2/2009)...sreal, December 2 Cardio...g developer of advanced,cardiovascular surgery tec...of Directors approved a one-for-three forward stoc...to Cardio Vascular Medical Device shareholders. ,...he estimated date the stock,split will be payable ...
(Date:12/2/2009)...., Dec. 2 Roche (SIX: RO...ed States Food & Drug Administration (FDA) app...nucleic acid test, to screen source plasma in pool...test, called the cobas® TaqScreen MPX Test fo...e, in-vitro test for the simultaneous, direct dete...
(Date:12/2/2009)...VER, N.J., Dec. 2 Novartis announc...presentation on Tasigna® (nilotinib) 200 mg c...onstrate the strength of the company,s hematology ..., The new data, at the 51st American Society of He...light the company,s current therapies and investig...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Advance in bowel cancer test research 48298 1Discovery raises new doubts about dinosaur bird links 8763 1Discovery raises new doubts about dinosaur bird links 8763 2Discovery raises new doubts about dinosaur bird links 8763 3Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
... WIRE)--Apr 23, 2007 - Aeolus,Pharmaceuticals, Inc...by researchers at Loma Linda University Medical Ce...hyrin antioxidants, AEOL,10113, may play an import...y ionizing radiation., Radiation therapy is used a...py in the care and management of nearly all adult ...
...eight loss medication Xenical,(orlistat 120mg) sig...lar risk factors such as blood pressure, glycaemic... people with type,2 diabetes and hypertension, acc...an Congress on Obesity (ECO), Budapest,Hungary.(1...already established,for Xenical that demonstrates ...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Wire Driver, Cannulated
Micro Saggital Saw
SmartDriver
Large Power Battery/Electric Reciprocating Saw
Medicine Products: